First Time Loading...

JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 2.55 HKD 3.66%
Updated: May 20, 2024

JW (Cayman) Therapeutics Co Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

JW (Cayman) Therapeutics Co Ltd
Net Income Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Net Income
-¥768m
CAGR 3-Years
23%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Net Income
-¥1.1B
CAGR 3-Years
-10%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Net Income
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is JW (Cayman) Therapeutics Co Ltd's Net Income?
Net Income
-768m CNY

Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Net Income amounts to -768m CNY.

What is JW (Cayman) Therapeutics Co Ltd's Net Income growth rate?
Net Income CAGR 5Y
-23%

Over the last year, the Net Income growth was 9%. The average annual Net Income growth rates for JW (Cayman) Therapeutics Co Ltd have been 23% over the past three years , -23% over the past five years .